Holen Sie sich die Stockscreener-App
144.94
1.61%
2.29
Vorhandelsmarkt:
147.05
2.11
+1.46%
Insulet Corp Aktie (PODD) Neueste Nachrichten
Insulet Device Correction Puts Omnipod Safety And Valuation In Focus - Yahoo Finance
TRADE SECRETS—Fed. Cir.: Medical device company’s $59.4 million judgment and injunction against South Korean competitor reversed - VitalLaw.com
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Eoflow: Stayin' Alive [U.S. Court of Appeals Overturns $59.4 Mn Trade Secret Verdict Vs Insulet] - Smartkarma
PODD News | INSULET CORP (NASDAQ:PODD) - ChartMill
Insulet Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Millions of Omnipods recalled due to manufacturing issue that may lead to complications - KMVT
Split Fed. Circ. Says $452M Trade Secret Case Was Untimely - Law360
US court overturns Insulet's $59 million insulin-pump trade secret verdict against EOFlow - Reuters
Insulet Corp. Stock Hits 52-Week Low at USD 141.02 Amid Decline - Markets Mojo
Insulet’s $59 Million Trade Secrets Award Voided on Appeal (1) - Bloomberg Law News
PODD Stock: What a Hold Rating Says at a $163 Target - Yahoo Finance
PODD Reiterated by RBC Capital -- Price Target Maintained at $28 - GuruFocus
Diabetes Insulin Pods Linked to 24 Serious Adverse Events Worldwide - mb.ntd.com
Insulet Corp. stock underperforms Wednesday when compared to competitors - MSN
Insulet Corp (PODD) Stock Down 5.1% -- Now Undervalued? GF Score: 82/100 - GuruFocus
Insulet Faces the Prospect of More Direct Competition From Peers - Morningstar
Insulet Corporation stock hits 52-week low at $143.95 By Investing.com - Investing.com Canada
William Blair Initiates on Insulet (PODD) With Outperform and Says the Valuation Gap Is Hard to Justify - Insider Monkey
Insulet initiates voluntary correction on Omnipod devices - BioWorld News
Diabetes device maker Insulet to webcast talk from William Blair event - Stock Titan
Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost - Reuters
Insulet recalls 7M insulin delivery pods due to safety risk - Cardiovascular Business
PODD Maintained by BTIG -- Price Target Lowered to $235 - GuruFocus
PODD and Omnipod 5: What's Driving Insulet's 2026 Growth - Yahoo Finance
Why is Insulet stock sliding today? - Investing.com
Insulet stock maintains Buy rating at Benchmark after recall - Investing.com
Why is Insulet stock sliding today? By Investing.com - Investing.com Canada
Insulet stock maintains Buy rating at Benchmark after recall By Investing.com - Investing.com Canada
Insulet Corporation stock hits 52-week low at $143.95 - Investing.com
Insulet recalls 7M patch pumps due to leak risk - Yahoo Finance
Insulet Corporation (PODD) Announces Voluntary Medical Device Co - GuruFocus
Insulet (PODD) Issues Medical Device Correction for Omnipod Prod - GuruFocus
Stocks to Watch: Zscaler, Verra Mobility, Digital Turbine, Insulet - Moomoo
Insulet stock tumbles on voluntary device recall - Investing.com
Insulet slides after updated Class I recall record for Omnipod 5 pods draws fresh attention - Quiver Quantitative
Insulet recalls 7 million Omnipod insulin pods due to leakage - Investing.com
Insulet (NASDAQ: PODD) faces Omnipod Pod correction, up to $50M 2026 cost - Stock Titan
Insulin pod safety alert: tear risk in 7M Omnipod devices - Stock Titan
Beta Bionics to launch its first insulin patch pump to compete with Insulet - Yahoo Finance
PODD Stock Price, Quote & Chart | INSULET CORP (NASDAQ:PODD) - ChartMill
11 Best Medical Technology Stocks to Buy Right Now - Insider Monkey
Are Wall Street Analysts Bullish on Insulet Stock? - Barchart.com
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
Here’s Insiders Fund’s Thesis on Insulet Corporation (PODD) - Insider Monkey
Insulet Corporation (PODD) Announces Amendments to Bylaws and An - GuruFocus
Insulet Corp (PODD) director granted 1,660 RSUs vesting in 2027 - Stock Titan
Insulet (PODD) director receives 1,660 RSU equity award vesting in 2027 - Stock Titan
Insulet (PODD) director Timothy Scannell receives 1,660-share RSU equity award - Stock Titan
Insulet (PODD) director Minogue receives 1,660 RSUs and reports trust-held shares - Stock Titan
Insulet (PODD) director awarded 1,660 RSUs in deferred stock grant - Stock Titan
Director at Insulet (NASDAQ: PODD) receives 1,660-share RSU grant - Stock Titan
Insulet (PODD) director granted 1,660 RSUs, total holdings now 3,818 shares - Stock Titan
Insulet (PODD) director Luciana Borio receives 1,660-share RSU equity grant - Stock Titan
Insulet (NASDAQ: PODD) amends bylaws and confirms 2026 shareholder voting outcomes - Stock Titan
Insulet Corp stock (US45784P1012): William Blair starts coverage as after-hours drop tests investor - AD HOC NEWS
PODD Assumed by William Blair -- Rating Action: Outperform - GuruFocus
Insulet’s SWOT analysis: stock faces mixed signals on growth - Investing.com
Insulet Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
0.59%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):